Your SlideShare is downloading. ×
The Use of Milnacipran in Treating Fibromyalgia
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

The Use of Milnacipran in Treating Fibromyalgia

662
views

Published on

The Use of Milnacipran in Treating Fibromyalgia

The Use of Milnacipran in Treating Fibromyalgia

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
662
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. The Use of Milnacipran inTreating Fibromyalgia
  • 2. Milnacipran, also known as milnacipranhydrochloride or Savella, helps to alleviate thepain caused by fibromyalgia through blocking thereuptake of serotonin and norepinephrine. Duringtwo double-blind clinical trials, Milcanipran hasbeen shown to decrease pain experienced bypatients with fibromyalgia by as much as 30percent. Furthermore, patients reporting the mostimprovement benefitted from the drug in as littleas one week after initiating treatment.
  • 3. Currently marketed by Forest Laboratories,Milnacipran was developed by CypressBiosciences, Inc., with support from physician andpharmaceutical investor Lindsay Rosenwald, MD,who co-founded Opus Point Partners, CougarBiotechnologies, Inc., and numerous othercompanies. Aided by his decades of experience inthe pharmaceutical industry, Dr. LindsayRosenwald played a major role in gaining FDAapproval for Milnacipran in 2009, and has securedapproval for the marketing of drugs for thetreatment of leukemia, prostate cancer, obesity,and rheumatoid arthritis as well.
  • 4. For more information on Milnacipran and CypressBioscience, visit www.cypressbio.com.